A three-gene assay for monitoring immune quiescence in kidney transplantation

Journal of the American Society of Nephrology

Volumn 26, Issue 8, 2015, Pages 2042-2053

  Roedder, Silke ^a   Li, Li ^b   Alonso, Michael N ^c   Hsieh, Szu Chuan ^a   Vu, Minh Thien ^a   Dai, Hong ^a   Sigdel, Tara K ^a   Bostock, Ian ^d   Macedo, Camila ^e   Metes, Diana ^e   Zeevi, Adrianna ^e   Shapiro, Ron ^e   Salvatierra, Oscar ^c   Scandling, John ^c   Alberu, Josefina ^d   Engleman, Edgar ^c   Sarwal, Minnie M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; B CELL ACTIVATING FACTOR; BASILIXIMAB; BELATACEPT; BNC2 PROTEIN; CREATININE; CYTOCHROME P450 1B1; DACLIZUMAB; KRUPPEL LIKE FACTOR 6; PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; BNC2 PROTEIN, HUMAN; CYP1B1 PROTEIN, HUMAN; DNA BINDING PROTEIN; GLYCOPROTEIN P 15095; KLF6 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; ONCOPROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CELL SELECTION; COMPARATIVE STUDY; COMPLEMENT SYSTEM; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DENDRITIC CELL; END STAGE RENAL DISEASE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FOLLOW UP; GENE EXPRESSION; GENETIC PROCEDURES; GRAFT RECIPIENT; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NATURAL KILLER CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THREE GENE ASSAY; ADOLESCENT; BLOOD; BLOOD CELL COUNT; CASE CONTROL STUDY; CHILD; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; HISTOCOMPATIBILITY; METABOLISM; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIGENS, CD11C; BIOMARKERS; BLOOD CELL COUNT; CASE-CONTROL STUDIES; CHILD; CYTOCHROME P-450 CYP1B1; DENDRITIC CELLS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS; TRANSPLANTATION IMMUNOLOGY; YOUNG ADULT;

EID: 84938925380     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013111239     Document Type: Article

References (43)

1. Veenstra DL, Best JH, Hornberger J, Sullivan SD, Hricik DE: Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 33: 829-839, 1999
2. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR: The natural history of chronic allograft nephropathy. N Engl J Med 349: 2326-2333, 2003
3. Serraino D, Piselli P, Busnach G, Burra P, Citterio F, Arbustini E, Baccarani U, De Juli E, Pozzetto U, Bellelli S, Polesel J, Pradier C, Dal Maso L, Angeletti C, Carrieri MP, Rezza G, Franceschi S; Immunosup-pression and Cancer Study Group: Risk of cancer following immuno-suppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer 43: 2117-2123, 2007
4. Chakkera HA, Mandarino LJ: Calcineurin inhibition and new-onset diabetes mellitus after transplantation. Transplantation 95: 647-652, 2013
5. Ashton-Chess J, Giral M, Brouard S, Soulillou JP: Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation. Transplantation 84: 1215-1219, 2007
6. Roussey-Kesler G, Giral M, Moreau A, Subra JF, Legendre C, Noel C, Pillebout E, Brouard S, Soulillou JP: Clinical operational tolerance after kidney transplantation. Am J Transplant 6: 736-746, 2006
7. Brouard S, Mansfield E, Braud C, Li L, Giral M, Hsieh SC, Baeten D, Zhang M, Ashton-Chess J, Braudeau C, Hsieh F, Dupont A, Pallier A, Moreau A, Louis S, Ruiz C, Salvatierra O, Soulillou JP, Sarwal M: Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 104: 15448-15453, 2007
8. Newell KA, Asare A, Kirk AD, Gisler TD, Bourcier K, Suthanthiran M, Burlingham WJ, Marks WH, Sanz I, Lechler RI, Hernandez-Fuentes MP, Turka LA, Seyfert-Margolis VL; Immune Tolerance Network ST507 Study Group: Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 120: 1836-1847, 2010
9. Sagoo P, Perucha E, Sawitzki B, Tomiuk S, Stephens DA, Miqueu P, Chapman S, Craciun L, Sergeant R, Brouard S, Rovis F, Jimenez E, Ballow A, Giral M, Rebollo-Mesa I, Le Moine A, Braudeau C, Hilton R, Gerstmayer B, Bourcier K, Sharif A, Krajewska M, Lord GM, Roberts I, Goldman M, Wood KJ, Newell K, Seyfert-Margolis V, Warrens AN, Janssen U, Volk HD, Soulillou JP, Hernandez-Fuentes MP, Lechler RI: Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 120: 1848-1861, 2010
10. Bohne F, Martínez-Llordella M, Lozano JJ, Miquel R, Benítez C, Londoño MC, Manzia TM, Angelico R, Swinkels DW, Tjalsma H, López M, Abraldes JG, Bonaccorsi-Riani E, Jaeckel E, Taubert R, Pirenne J, Rimola A, Tisone G, Sánchez-Fueyo A: Intra-graft expression of genes involved in iron ho-meostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest 122: 368-382, 2012
11. Li L, Wozniak LJ, Rodder S, Heish S, Talisetti A, Wang Q, Esquivel C, Cox K, Chen R, McDiarmid SV, Sarwal MM: A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation. Am J Transplant 12: 1218-1228, 2012
12. Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, Hodge CL, Haase J, Janes J, Huss JW 3rd, Su AI: BioGPS: An extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10: R130, 2009
13. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001
14. Tibshirani R, Hastie T, Narasimhan B, Chu G: Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 99: 6567-6572, 2002
15. Chen R, Li L, Butte AJ: AILUN: Reannotating gene expression data automatically. Nat Methods 4: 879, 2007
16. Vincenti F, Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G, Lang P, Grinyo J, Halloran PF, Solez K, Hagerty D, Levy E, Zhou W, Natarajan K, Charpentier B; Belatacept Study Group: Costimulation blockade with belatacept in renal transplantation. N Engl J Med 353: 770-781, 2005
17. Cao Z, Sun X, Icli B, Wara AK, Feinberg MW: Role of Kruppel-like factors in leukocyte development, function, and disease. Blood 116: 4404-4414, 2010
18. Nebert DW, Russell DW: Clinical importance of the cytochromes P450. Lancet 360: 1155-1162, 2002
19. Bernhardt R: Cytochromes P450 as versatile biocatalysts. J Biotechnol 124: 128-145, 2006
20. Sánchez-Fueyo A, Strom TB: Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gas-troenterology 140: 51-64, 2011
21. Martínez-Llordella M, Lozano JJ, Puig-Pey I, Orlando G, Tisone G, Lerut J, Benítez C, Pons JA, Parrilla P, Ramírez P, Bruguera M, Rimola A, Sánchez-Fueyo A: Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 118: 2845-2857, 2008
22. Lozano JJ, Pallier A, Martinez-Llordella M, Danger R, Lopez M, Giral M, Londono MC, Rimola A, Soulillou JP, Brouard S, Sanchez-Fueyo A: Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant 11: 1916-1926, 2011
23. Maecker B, von Bergwelt-Baildon MS, Anderson KS, Vonderheide RH, Anderson KC, Nadler LM, Schultze JL: Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients. Clin Exp Immunol 141: 558-562, 2005
24. Maecker B, von Bergwelt-Baildon MS, Sherr DH, Nadler LM, Schultze JL: Identification of a new HLA-A∗0201-restricted cryptic epitope from cyp1b1. Int J Cancer 115: 3333-336, 2005
25. Moreau A, Varey E, Bériou G, Hill M, Bouchet-Delbos L, Segovia M, Cuturi MC: Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials. Front Immunol 3: 218, 2012
26. Raimondi G, Thomson AW: Dendritic cells, tolerance and therapy of organ allograft rejection. Contrib Nephrol 146: 105-120, 2005
27. Morelli AE, Thomson AW: Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7: 610-621, 2007
28. Riquelme P, Geissler EK, Hutchinson JA: Alternative approaches to my-eloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs. Transp Res 1: 17, 2012
29. Geissler EK: The ONE Study compares cell therapy products in organ transplantation: Introduction to a review series on suppressive mono-cyte-derived cells. Transp Res 1: 11, 2012
30. Brouard S, Le Bars A, Dufay A, Gosselin M, Foucher Y, Guillet M, Cesbron-Gautier A, Thervet E, Legendre C, Dugast E, Pallier A, Guillot-Gueguen C, Lagoutte L, Evanno G, Giral M, Soulillou JP: Identification of a gene expression profile associated with operational tolerance among a selected group of stable kidney transplant patients. Transplant Int 24: 536-547, 2011
31. Brouard S, Pallier A, Renaudin K, Foucher Y, Danger R, Devys A, Cesbron A, Guillot-Guegen C, Ashton-Chess J, Le Roux S, Harb J, Roussey G, Subra JF, Villemain F, Legendre C, Bemelman FJ, Orlando G, Garnier A, Jambon H, Le Monies De Sagazan H, Braun L, Noel C, Pillebout E, Moal MC, Cantarell C, Hoitsma A, Ranbant M, Testa A, Soulillou JP, Giral M: The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant 12: 3296-3307, 2012
32. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ: Banff '05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('can'). Am J Transplant 7: 518-526, 2007
33. Yilmaz S, Tomlanovich S, Mathew T, Taskinen E, Paavonen T, Navarro M, Ramos E, Hooftman L, Häyry P: Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies. J Am Soc Nephrol 14: 773-779, 2003
34. Sarwal MM, Ettenger RB, Dharnidharka V, Benfield M, Mathias R, Portale A, McDonald R, Harmon W, Kershaw D, Vehaskari VM, Kamil E, Baluarte HJ, Warady B, Tang L, Liu J, Li L, Naesens M, Sigdel T, Waskerwitz J, Salvatierra O: Complete steroid avoidance is effective and safe in children with renal transplants: A multicenter randomized trial with three-year follow-up. Am J Transplant 12: 2719-2729, 2012
35. Li L, Chaudhuri A, Chen A, Zhao X, Bezchinsky M, Concepcion W, Salvatierra O Jr, Sarwal MM: Efficacy and safety of thymoglobulin induction as an alternative approach for steroid-free maintenance immunosuppression in pediatric renal transplantation. Transplantation 90: 1516-1520, 2010
36. Uslu A, Nart A, Coker I, Köse S, Aykas A, Kahya MC, Yüzbasioglu MF, Dogan M: Two-day induction with thymoglobulin in kidney transplantation: Risks and benefits. Transplant Proc 36: 76-79, 2004
37. Ortiz J, Palma-Vargas J, Wright F, Bingaman A, Agha I, Rosenblatt S, Foster P: Campath induction for kidney transplantation: report of 297 cases. Transplantation 85: 1550-1556, 2008
38. Thomas PG, Woodside KJ, Lappin JA, Vaidya S, Rajaraman S, Gugliuzza KK: Alemtuzumab (Campath 1H) induction with tacrolimus mono-therapy is safe for high immunological risk renal transplantation. Transplantation 83: 1509-1512, 2007
39. Malek SK, Obmann MA, Gotoff RA, Foltzer MA, Hartle JE, Potdar S: Campath-1H induction and the incidence of infectiouscomplications in adult renal transplantation. Transplantation 81: 17-20, 2006
40. Vincenti F, Charpentier B, Vanrenterghem Y, Rostaing L, Bresnahan B, Darji P, Massari P, Mondragon-Ramirez GA, Agarwal M, Di Russo G, Lin CS, Garg P, Larsen CP: A phase III study of belatacept-based immu-nosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 10: 535-546, 2010
41. Li L, Khatri P, Sigdel TK, Tran T, Ying L, Vitalone MJ, Chen A, Hsieh S, Dai H, Zhang M, Naesens M, Zarkhin V, Sansanwal P, Chen R, Mindrinos M, Xiao W, Benfield M, Ettenger RB, Dharnidharka V, Mathias R, Portale A, McDonald R, Harmon W, Kershaw D, Vehaskari VM, Kamil E, Baluarte HJ, Warady B, Davis R, Butte AJ, Salvatierra O, Sarwal MM: Aperipheral blood diagnostic test for acute rejection in renal transplantation. Am J Transplant 12: 2710-2718, 2012
42. Halbritter F, Vaidya HJ, Tomlinson SR: GeneProf: Analysis of high-throughput sequencing experiments. Nat Methods 9: 7-8, 2012
43. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001